MESO Mesoblast Limited
$15.48▼ -0.13%
Healthcare
Other
After hours
$15.48▲ +0.00%
Sep 11, 7:30 PM ET
Volume 180.2K
Avg Volume (10D) 212.8K
Key Metrics & Fundamentals
Market Cap
$2.01B
P/E Ratio
–
Div Yield
–%
52W Range
13.05 - 21.50
% vs 50 MA
-3.90%
% vs 200 MA
-4.06%
RSI-14
42.5
MACD Histogram
-0.2500
Beta (1Y vs SPY)
1.47
Free Cash Flow
-$9.32M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Fast Growing ASX Stocks With High Insider Ownership Worth Watching
Simply Wall St. · Aug 30, 2026 12:16 PM
PDI Gold Stock Leads These Fast Growing Insider Backed Commodity Picks
Simply Wall St. · Aug 29, 2026 2:17 AM
Mesoblast Fiscal 2026 Loss Narrows, Revenue Rises
MT Newswires · Aug 27, 2026 7:56 AM
Alkane Resources Stock Tops Financially Fit Penny Stocks For Australian Investors
Simply Wall St. · Aug 27, 2026 2:15 AM
Mesoblast Reports Substantial Revenue Growth to US$120M
GlobeNewswire · Aug 27, 2026 12:32 AM
Why Retail Investors Are Tracking These 3 Founder Led Australian Stocks Today
Simply Wall St. · Aug 27, 2026 12:24 AM
Mesoblast H2 Earnings Call Highlights
MarketBeat · Aug 27, 2026 12:02 AM
3 Australian Growth Stocks With Strong Balance Sheets In A Rate Hike Debate
Simply Wall St. · Aug 26, 2026 4:21 PM
Mesoblast Financial Results and Corporate Update Webcast
GlobeNewswire · Aug 24, 2026 11:00 AM
MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up
Zacks · Aug 18, 2026 3:46 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MESO's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.